The drug Bendamustine is used to treat patients who have chronic lymphocytic leukemia and non-Hodgkin’s lymphoma. The multiple-doses vials of Bendamustine come in 100 mg for intravenous administration. The injection is supplied as sterile, clear, and colorless to a yellow ready-to-dilute solution. The active ingredient in the medicine is Bendamustine hydrochloride, and the inactive ingredients are propylene glycol, monothioglycerol, in polyethylene glycol. …

Bendamustine is an alkylating drug; it is a bifunctional mechlorethamine derivative containing a purine-like benzimidazole ring. This medicine comes in single-use vials for intravenous infusion in 100 mg. The active ingredient in the drug is Bendamustine hydrochloride, and the inactive ingredient is mannitol. One should take this medicine as per the prescription of the doctor. Bendamustine is used in treating chronic lymphocytic leukemia and non-Hodgkin’s lymphoma.…

The drug Lenalidomide is a thalidomide analogue, is an immunomodulatory agent with antiangiogenic and antineoplastic properties. Lenalidomide is present as an off-white to pale-yellow solid powder, and the capsules of Lenalidomide come in the strengths of 5 mg, 10 mg, 15 mg, and 25 mg for oral administration. The active ingredient in the capsule is Lenalidomide, and the inactive ingredients are lactose anhydrous, microcrystalline cellulose, croscarmellose sodium, and magnesium stearate.…

The drug Carfilzomib is sold under the trade name Kyprolis. It is used in treating patients with multiple myeloma and has received at least a couple of prior therapies, including bortezomib and an immunomodulatory agent. Carfilzomib is a tetrapeptide epoxyketone proteasome inhibitor that irreversibly binds to the N-terminal threonine-containing active sites of the 20S proteasome, the proteolytic core particle within the 26S proteasome. It is an antineoplastic agent available for intravenous…

Healthcare professionals use the drug Bortezomib in treating patients who have multiple myeloma and mantle cell lymphoma. Bortezomib is a reversible inhibitor of the chymotrypsin-like activity of the 26S proteasome in cells of mammals. The 26S proteasome is a large protein complex that degrades ubiquitinated proteins. The drug Bortezomib single-vial comes in 2 mg for subcutaneous and intravenous infusion. The active ingredient in the vials is Bortezomib, with the inactive ingredient…

Bendamustine 50 mg is a unique alkylating agent, which combines a nitrogen mustard moiety of mechlorethamine with a benzimidazole. The bendamustine 50 mg injection has shown promising clinical activity against a range of hematologic malignancies and solid tumors as a single agent or along with certain other anticancer agents. This medicinal product is indicated for the treatment of patients with chronic…

Cytarabine is found in a sterile, preservative-free, purple, lyophilized cake in a single-dose vial. This medicine is used in treating patients with acute myeloid leukemia or AML with myelodysplasia-related changes. Cytarabine comes in 100 mg, 500 mg, and 1000 mg for intravenous administration. One should administer this medication according to the prescription of the healthcare professional.

Cytarabine injection…

Rituximab is a CD20-directed cytolytic antibody, which healthcare professionals use for treating patients with Non–Hodgkin’s Lymphoma (NHL), Chronic Lymphocytic Leukemia (CLL), rheumatoid arthritis, Granulomatosis with Polyangiitis, and Microscopic Polyangiitis (MPA) and moderate to severe pemphigus Vulgaris. The single-dose vials of Rituximab come in 500 mg/50 mL (10 mg/mL) to administer intravenously. Rituximab is produced in Chinese Hamster Ovary suspension culture in a nutrient medium…

The medicine Arsenic Trioxide is a sterile, nonpyrogenic, clear solution. Healthcare professionals recommend this drug to treat patients who have acute promyelocytic leukaemia (APL) who are refractory to or have relapsed from retinoid and anthracycline chemotherapy and whose APL is characterized by the presence of the t(15;17) translocation or PML/RAR-alpha gene expression. Arsenic trioxide does morphological changes and DNA fragmentation characteristic of apoptosis in NB4 human…

Cytarabine injection helps stop cells from forming DNA and may kill malignant cells. It is a type of antimetabolite. Also known as ARA-C. The cytarabine injection price might vary depending on a wide range of generic and innovator version drugs. Cytarabine is a medication used with other medicines for the treatment of adults and children with acute myeloid leukemia (AML) and for the prevention and treatment of a…

The medicine Arsenic Trioxide is recommended by healthcare professionals for treating patients with acute promyelocytic leukemia who are refractory to or have relapsed from retinoid and anthracycline chemotherapy and whose APL is characterized by the presence of the t(15;17) translocation or PML/RAR-alpha gene expression. The active ingredient in the medicine is Arsenic Trioxide, and the inactive ingredients are sodium hydroxide and hydrochloric acid.…

Bendamustine is a bifunctional mechlorethamine derivative containing a purine-like benzimidazole ring. Mechlorethamine and its derivatives form electrophilic alkyl groups. Bendamustine is used by healthcare professionals in the treatment of patients with chronic lymphocytic leukemia and non-Hodgkin’s lymphoma. The active ingredient in the medicine is Bendamustine hydrochloride, and the inactive ingredients are propylene glycol, monothioglycerol, in polyethylene glycol. Bendamustine injection…

Carfilzomib 60 mg is approved as a chemotherapy agent to treat patients with multiple myeloma who have taken single or multiple lines of therapy. The carfilzomib 60 mg injection price in India is less than the other countries due to the availability of both biosimilar drugs and their brand-name counterparts. The proposed dosing regimen of Carfilzomib 60 mg can be administered once or twice weekly, and your…

Healthcare providers use Bendamustine in treating patients who have chronic lymphocytic leukemia and non-Hodgkin’s lymphoma. This drug comes in single-use vials in 100 mg to inject intravenously. The recommended dosage of Bendamustine is 100 mg/m2 administered intravenously over 10 minutes on Days 1 and 2 of a 28-day cycle, up to 6 cycles. Bendamustine is an alkylating agent.

Bendamustine injection 100…

Pomalidomide is an analog of thalidomide drug, which healthcare professionals use to treat patients with multiple myeloma. It is an immunomodulatory agent with antineoplastic activity. In trials, Pomalidomide inhibited proliferation and induced apoptosis of hematopoietic tumor cells. Moreover, Pomalidomide inhibited the proliferation of lenalidomide-resistant multiple myeloma cell lines and synergized with dexamethasone in both lenalidomide-sensitive and lenalidomide-resistant cell lines to…